ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.394,93
-0,11%
S&P 500
6.101,24
-0,29%
Dow Jones
44.424,25
-0,32%
Euro vs US Dollar
1,05025
-0,01%
Bitcoin
104.685,43
-0,16%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Qualigen Therapeutics Inc (QLGN)

  7. Qualigen Therapeutics Inc (QLGN) News

QLGN

Qualigen Therapeutics (QLGN)

Qualigen Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:QLGN
DatumZeitQuelleÜberschriftSymbolFirma
26/12/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
20/12/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:QLGNQualigen Therapeutics Inc
10/12/202420h27Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:QLGNQualigen Therapeutics Inc
05/12/202415h00GlobeNewswire Inc.Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity RequirementNASDAQ:QLGNQualigen Therapeutics Inc
25/11/202423h00GlobeNewswire Inc.Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)NASDAQ:QLGNQualigen Therapeutics Inc
22/11/202423h28Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:QLGNQualigen Therapeutics Inc
21/11/202423h10Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:QLGNQualigen Therapeutics Inc
21/11/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
19/11/202415h00GlobeNewswire Inc.Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred SharesNASDAQ:QLGNQualigen Therapeutics Inc
15/11/202422h05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:QLGNQualigen Therapeutics Inc
14/11/202422h25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QLGNQualigen Therapeutics Inc
13/11/202423h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
08/11/202423h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
01/11/202421h55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
01/11/202414h00GlobeNewswire Inc.Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024NASDAQ:QLGNQualigen Therapeutics Inc
29/10/202421h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
24/10/202423h06Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:QLGNQualigen Therapeutics Inc
22/10/202422h35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
17/10/202422h05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:QLGNQualigen Therapeutics Inc
09/10/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
09/10/202422h10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:QLGNQualigen Therapeutics Inc
26/09/202423h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
26/09/202423h10GlobeNewswire Inc.Qualigen Therapeutics, Inc. Announces management changes.NASDAQ:QLGNQualigen Therapeutics Inc
20/09/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
20/09/202415h00GlobeNewswire Inc.Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings PanelNASDAQ:QLGNQualigen Therapeutics Inc
09/09/202423h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
06/09/202423h00GlobeNewswire Inc.Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN)NASDAQ:QLGNQualigen Therapeutics Inc
06/09/202422h30GlobeNewswire Inc.Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public OfferingNASDAQ:QLGNQualigen Therapeutics Inc
06/09/202421h46Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:QLGNQualigen Therapeutics Inc
05/09/202415h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:QLGN

Kürzlich von Ihnen besucht

NYSE
JPM
JP Morgan Chase
NYSE
MRK
Merck
CCOM
US30
US 30
TG
MBG
MercedesBenz
USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
US500
US 500
TG
NOV
Novo Nordisk
DBI
MDAX
MDAX
DBI
DAX
DAX
NYSE
DIS
Walt Disney
NASDAQ
GOOGL
Alphabet
NASDAQ
AMZN
Amazon.com
NASDAQ
QQQ
Invesco QQQ Trust Series 1
TG
BAYN
Bayer
TG
CBK
Commerzbank
TG
BAS
BASF
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten